Feldan Therapeutics

📍 Québec City, Canada🗓 Founded 2007👥 35 employees💰 Last funded Feb 2015
Feldan is a biopharmaceutical company that specializes in the development of treatments based on the intracellular delivery of therapeutics. Feldan designed a proprietary, peptide-based technology that enables safe and efficient delivery of various compounds inside cells. The Shuttle technology unlocks the development of a new generation of therapies by giving access to intracellular components beyond the reach of existing drugs. Feldan's pipeline focuses on diseases affecting skin and lungs. Since its beginning, Feldan has valued internal research with the aim of innovating, changing standards of care and redefining quality of life. With the development of the Feldan Shuttle, this approach is starting to show its promises.
3
Total investors
0
Early stage
0
Mid stage
3
Late stage
2007
Founded
Investor geography1 country
Canada
2
Frequently asked questions
Who invested in Feldan Therapeutics?
Feldan Therapeutics has 3 investors on record on gritt.io and 3 late-stage investors.
When did Feldan Therapeutics last raise funding?
The most recent investment in Feldan Therapeutics recorded on gritt.io was in February 2015.
When was Feldan Therapeutics founded?
Feldan Therapeutics was founded in 2007.
What industry is Feldan Therapeutics in?
Feldan Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Feldan Therapeutics based?
Feldan Therapeutics is headquartered in Québec City, Canada.